(NASDAQ: AXGN) Axogen's forecast annual revenue growth rate of 18.26% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.28%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.47%.
Axogen's revenue in 2026 is $251,174,000.On average, 12 Wall Street analysts forecast AXGN's revenue for 2026 to be $15,330,095,432, with the lowest AXGN revenue forecast at $14,699,472,884, and the highest AXGN revenue forecast at $15,845,668,342. On average, 12 Wall Street analysts forecast AXGN's revenue for 2027 to be $18,404,716,360, with the lowest AXGN revenue forecast at $16,906,920,608, and the highest AXGN revenue forecast at $20,632,593,459.
In 2028, AXGN is forecast to generate $22,588,974,917 in revenue, with the lowest revenue forecast at $20,542,274,117 and the highest revenue forecast at $24,431,381,968.